MP:0001183 | overexpanded alveoli | "expanded volume of the saclike terminal dilation of the respiratory bronchioles" [J:66345] |
Show
Allelic Composition: Ltbp4Gt(U3Cre)1Vmel/Ltbp4Gt(U3Cre)1Vmel Genetic Background: involves: 129S2/SvPas
|
MP:0001759 | increased urine glucose level | "a greater level of excretion of glucose in the urine compared to the normal state" [csmith:Cynthia L. Smith, Mouse Genome Informatics Curator] |
Show
Allelic Composition: Sesn2Gt(RRJ141)Byg/Sesn2Gt(RRJ141)Byg,Sesn3tm1a(EUCOMM)Wtsi/Sesn3tm1a(EUCOMM)Wtsi Genetic Background: involves: 129P2/OlaHsd * C57BL/6N
|
MP:0002628 | fatty liver | "an accumulation of fat deposits in the liver " [pvb:Pierre Vanden Borre , Mouse Genome Informatics Curator] |
Show
Allelic Composition: Prkntm1Ykt/Prkntm1Ykt,Tg(Prp-GPR37)1Ryot/Tg(Prp-GPR37)1Ryot Genetic Background: involves: 129P2/OlaHsd * C3H * C57BL/6
Allelic Composition: Lepob/Lepob,Sesn2Gt(RRJ141)Byg/Sesn2Gt(RRJ141)Byg Genetic Background: involves: 129P2/OlaHsd * C57BL/6
|
MP:0003383 | abnormal gluconeogenesis | "anomaly in the formation of glucose from noncarbohydrates, such as proteins or fat" [J:93896] |
Show
Allelic Composition: Prkntm1Ykt/Prkntm1Ykt,Tg(Prp-GPR37)1Ryot/Tg(Prp-GPR37)1Ryot Genetic Background: involves: 129P2/OlaHsd * C3H * C57BL/6
|
MP:0005293 | impaired glucose tolerance | "less than the normal response to oral consumption or intravenous injection of specified amounts of glucose and indicative of insulin resistance; measured by determining whole blood or plasma sugar level in a fasting state before and after taking glucose at specified intervals" [MeSH:National Library of Medicine - Medical Subject Headings , 2003] |
Show
Allelic Composition: Prkntm1Ykt/Prkntm1Ykt,Tg(Prp-GPR37)1Ryot/Tg(Prp-GPR37)1Ryot Genetic Background: involves: 129P2/OlaHsd * C3H * C57BL/6
Allelic Composition: Sesn2Gt(RRJ141)Byg/Sesn2Gt(RRJ141)Byg,Sesn3tm1a(EUCOMM)Wtsi/Sesn3tm1a(EUCOMM)Wtsi Genetic Background: involves: 129P2/OlaHsd * C57BL/6N
Allelic Composition: Lepob/Lepob,Sesn2Gt(RRJ141)Byg/Sesn2Gt(RRJ141)Byg Genetic Background: involves: 129P2/OlaHsd * C57BL/6
|
MP:0005331 | insulin resistance | "diminished effectiveness of insulin in lowering plasma glucose levels" [Stedman s Medical Dictionary:ISBN 0-683-40008-8, J:84260, pvb:Pierre Vanden Borre , Mouse Genome Informatics Curator] |
Show
Allelic Composition: Prkntm1Ykt/Prkntm1Ykt,Tg(Prp-GPR37)1Ryot/Tg(Prp-GPR37)1Ryot Genetic Background: involves: 129P2/OlaHsd * C3H * C57BL/6
Allelic Composition: Sesn2Gt(RRJ141)Byg/Sesn2Gt(RRJ141)Byg,Sesn3tm1a(EUCOMM)Wtsi/Sesn3tm1a(EUCOMM)Wtsi Genetic Background: involves: 129P2/OlaHsd * C57BL/6N
Allelic Composition: Lepob/Lepob,Sesn2Gt(RRJ141)Byg/Sesn2Gt(RRJ141)Byg Genetic Background: involves: 129P2/OlaHsd * C57BL/6
|
MP:0005559 | increased circulating glucose level | "greater than the normal concentration in the blood of this major monosaccharide of the body; it is an important energy source" [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator, RGD:Rat Genome Database submission] |
Show
Allelic Composition: Lepob/Lepob,Sesn2Gt(RRJ141)Byg/Sesn2Gt(RRJ141)Byg Genetic Background: involves: 129P2/OlaHsd * C57BL/6
|
MP:0008260 | abnormal autophagy | "abnormal catabolic process involving the degradation of a cell s own components through the lysosomal machinery" [MGI:honda "Hiraoki Onda, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Prkntm1Ykt/Prkntm1Ykt,Tg(Prp-GPR37)1Ryot/Tg(Prp-GPR37)1Ryot Genetic Background: involves: 129P2/OlaHsd * C3H * C57BL/6
|
MP:0008406 | increased cellular sensitivity to hydrogen peroxide | "greater incidence of cell death following exposure to hydrogen peroxide" [MGI:csmith "Cynthia L. Smith, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Tyrc-Bc3/Tyrc-Bc3 Genetic Background: SELH/Bc
|
MP:0009355 | increased liver triglyceride level | "higher than normal concentration of triacylglycerols in the liver" [MGI:smb "Susan M. Bello, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Prkntm1Ykt/Prkntm1Ykt,Tg(Prp-GPR37)1Ryot/Tg(Prp-GPR37)1Ryot Genetic Background: involves: 129P2/OlaHsd * C3H * C57BL/6
Allelic Composition: Lepob/Lepob,Sesn2Gt(RRJ141)Byg/Sesn2Gt(RRJ141)Byg Genetic Background: involves: 129P2/OlaHsd * C57BL/6
|
MP:0011629 | decreased mitochondria number | "fewer than normal number of the cellular organelles responsible for energy production" [MGI:csmith] |
Show
Allelic Composition: Prkntm1Ykt/Prkntm1Ykt,Tg(Prp-GPR37)1Ryot/Tg(Prp-GPR37)1Ryot Genetic Background: involves: 129P2/OlaHsd * C3H * C57BL/6
|
MP:0011639 | decreased mitochondrial DNA content | "less than expected amount of DNA contained within the mirochondria of a eukaryotic cell" [MGI:csmith] |
Show
Allelic Composition: Prkntm1Ykt/Prkntm1Ykt,Tg(Prp-GPR37)1Ryot/Tg(Prp-GPR37)1Ryot Genetic Background: involves: 129P2/OlaHsd * C3H * C57BL/6
|
MP:0011807 | decreased lung fibroblast proliferation | "reduction in the expansion rate of a lung fibroblast cell population by cell division" [MGI:csmith] |
Show
Allelic Composition: Tyrc-Bc3/Tyrc-Bc3 Genetic Background: SELH/Bc
|
MP:0013501 | increased fibroblast apoptosis | "increase in the timing or the number of fibroblast cells undergoing programmed cell death" [MGI:csmith] |
Show
Allelic Composition: Tyrc-Bc3/Tyrc-Bc3 Genetic Background: SELH/Bc
|
MP:0014174 | decreased fatty acid beta-oxidation | "decreased rate or incidence of the process that results in the complete oxidation of a long-chain fatty acid, beginning with the addition of coenzyme A to a fatty acid, with successive cycles of reactions during each of which the fatty acid is shortened by a two-carbon fragment removed as acetyl coenzyme A; the cycle continues until only two or three carbons remain (as acetyl-CoA or propionyl-CoA respectively)" [GO:0006635] |
Show
Allelic Composition: Lepob/Lepob,Sesn2Gt(RRJ141)Byg/Sesn2Gt(RRJ141)Byg Genetic Background: involves: 129P2/OlaHsd * C57BL/6
|
MP:0030017 | decreased adipocyte glucose uptake | "reduced ability of adipocytes to take in glucose" [MGI:anna] |
Show
Allelic Composition: Prkntm1Ykt/Prkntm1Ykt,Tg(Prp-GPR37)1Ryot/Tg(Prp-GPR37)1Ryot Genetic Background: involves: 129P2/OlaHsd * C3H * C57BL/6
|